Skip to content
Screener

PP&E (Net) at other companies

Schrodinger logo
SchrodingerSDGR
$19.46M-10.4%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$89.62M-25.3%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$1.28M-26.5%
Assembly Biosciences logo
Assembly BiosciencesASMB
$214K-14.7%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$3.84M+1.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$5.23M-14.4%

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.41B+235%
Enterprise value$1.4B+279%
P/S765.8×+664×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization.

The source filing: Absci Corporation’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:24 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001672688-26-000088
(In thousands, except for share and per share data)March 31, 2026December 31, 2025
Prepaid expenses and other current assets6,2675,281
Total current assets131,972149,573
Operating lease right-of-use assets2,6302,914
Property and equipment, net18,77820,860
Intangibles, net40,76841,514
Restricted cash, long-term1,0621,053
Other long-term assets383383
TOTAL ASSETS$195,593$216,297

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is Absci Corporation's PP&E (net)?
Absci Corporation (ABSI) reported PP&E (net) of $18.78M in Q1 2026.
How has Absci Corporation's PP&E (net) changed year-over-year?
Absci Corporation's PP&E (net) decreased by 30.5% year-over-year, from $27.03M to $18.78M.
What is the long-term trend for Absci Corporation's PP&E (net)?
Over 5 years (2020 to 2025), Absci Corporation's PP&E (net) has grown at a 18.5% compound annual growth rate (CAGR), from $8.91M to $20.86M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Ask your AI about Absci Corporation's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude